phase 2_initiation
saveGlenmark Pharmaceuticals Ltd — (clascoterone + latanoprost) (Phase II Trial Initiation)
community read0 votes
Therapy area: Dermatology. Indication: Androgenic Alopecia
Data sources
globaldata
Found something off?
same company · ±60 days · 5
- approvalLAMOTRIGINE: LAMOTRIGINE — FDA approvalApr 17, 2026
- approvalLAMOTRIGINE: LAMOTRIGINE — FDA approvalApr 17, 2026
- approvalLAMOTRIGINE: LAMOTRIGINE — FDA approvalApr 10, 2026
- approvalPROGESTERONE: PROGESTERONE — FDA approvalApr 8, 2026
- approvalFluticasone Propionate Glenmark: FLUTICASONE PROPIONATE — FDA approvalMar 16, 2026
comments(0)
5-min edit window · permanent after that